Johnson & Johnson
JNJ
#26
Rank
NZ$629.23 B
Marketcap
$261.35
Share price
-0.66%
Change (1 day)
2.12%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2024 (TTM): NZ$141.90 Billion

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM ) is NZ$149.03 Billion. In 2023 the company made a revenue of NZ$134.66 Billion a decrease over the revenue in the year 2022 that were of NZ$143.56 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$141.90 B5.38%
2023 NZ$134.66 B-6.2%
2022 NZ$143.56 B4.57%
2021 NZ$137.29 B19.95%
2020 NZ$114.45 B-6.06%
2019 NZ$121.84 B0.18%
2018 NZ$121.62 B12.98%
2017 NZ$107.64 B3.72%
2016 NZ$103.78 B1.37%
2015 NZ$102.38 B7.92%
2014 NZ$94.86 B9.32%
2013 NZ$86.77 B6.19%
2012 NZ$81.71 B-1.93%
2011 NZ$83.32 B4.38%
2010 NZ$79.82 B-6.33%
2009 NZ$85.21 B-22.42%
2008 NZ$109.84 B37.73%
2007 NZ$79.75 B5.38%
2006 NZ$75.69 B2.42%
2005 NZ$73.90 B11.38%
2004 NZ$66.35 B3.04%
2003 NZ$64.39 B-7.15%
2002 NZ$69.35 B-11.37%
2001 NZ$78.25 B17.41%
2000 NZ$66.64 B25.18%
1999 NZ$53.24 B18.6%
1998 NZ$44.88 B15.12%
1997 NZ$38.99 B27.43%
1996 NZ$30.60 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$102.15 B-31.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$107.36 B-27.96%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$84.87 B-43.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$90.93 B-38.99%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$37.34 B-74.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$55.36 B-62.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$69.44 B-53.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$70.04 B-53.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$68.40 B-54.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$48.09 B-67.73%๐Ÿ‡บ๐Ÿ‡ธ USA